Chemotherapy-induced neutropenia is a major risk factor for infection-related morbidity and mortality and an important dose-limiting toxicity in cancer treatment. The incidence of severe ...

Objective: To systematically evaluate the literature to determine whether vancomycin-induced neutropenia is dose- or duration-related and provide clinicians with feasible treatment alternatives.

Late-onset neutropenia (LON) is emerging as a common ... The mechanisms of LON seem to be multifactorial and are related to rituximab-induced B lymphopenia. LON is self-limited in the majority ...

BeyondSpring Inc.’s BYSI share price has surged by 12.89%, which has investors questioning if this is right time to sell.